Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

38.96 -3.53 (-8.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,249,241
Open 42.58
Bid (Size) 38.90 (1)
Ask (Size) 44.00 (1)
Prev. Close 42.49
Today's Range 38.89 - 42.89
52wk Range 18.80 - 60.90
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire

Performance

YTD
+12.47%
+12.47%
1 Month
-15.87%
-15.87%
3 Month
-13.42%
-13.42%
6 Month
-16.22%
-16.22%
1 Year
+95.78%
+95.78%

More News

Read More
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Evaluating Twist Bioscience: Insights From 5 Financial Analysts
Via Benzinga
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
From Absci Corporation
Via GlobeNewswire
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
From Twist Bioscience Corporation
Via Business Wire
Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
Via Benzinga
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
From Twist Bioscience Corporation
Via Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
From Twist Bioscience Corporation
Via Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
From FN Media Group LLC
Via GlobeNewswire
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
Via InvestorPlace
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday
Via Benzinga
The 3 Best Med Tech Stocks to Buy Now
Via InvestorPlace
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025
Via Benzinga
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.